anayamalik, Author at European Medical Journal - Page 71 of 120

Is Parkinson’s Disease Rooted in the Gut?

Parkinson’s disease (PD), a progressive neurodegenerative disorder impacting over 10 million people worldwide, is defined by the aggregation of misfolded α-synuclein (aSyn) in the substantia nigra pars compacta, leading to the hallmark motor symptoms of tremor, rigidity, and bradykinesia.

Can a Single Flu Pill Reduce Transmission?

A recent Phase IIIb multicountry study has demonstrated that a single oral dose of an antiviral flu treatment can significantly reduce the transmission of influenza within households, offering a potential new strategy for healthcare professionals to mitigate spread during flu season.

Study Reveals Sleep Loss May Spark Autoimmune Conditions

Chronic insomnia, already known for its toll on mental and physical health, has now been linked to an increased risk of developing specific autoimmune diseases, according to a recent large-scale cohort study conducted in the United States.

Transient Blastocystis Transmission Observed After Fresh FMT

Fecal microbiota transplantation (FMT), an emerging therapy for conditions like irritable bowel syndrome (IBS), continues to raise questions about the safety of transferring certain microorganisms, especially the intestinal parasite Blastocystis spp.

Heart Rate Variability Grading Links to Fibromyalgia Severity

A recent study offers fresh insights into how heart rate variability (HRV) measures, both linear and nonlinear, can help detect autonomic nervous system dysfunction in fibromyalgia (FM), a chronic condition marked by widespread pain, fatigue, and mood disturbances.

Psychiatric Symptoms Foretell Alzheimer's Progression

Persistent neuropsychiatric symptoms (NPS) in older adults could serve as early warning signs of underlying Alzheimer’s disease (AD) pathology, according to new research.

Genetic Clues Behind P. aeruginosa Drug Resistance

Pseudomonas aeruginosa, a leading cause of microbial keratitis, continues to challenge clinicians with rising antimicrobial resistance.

New Treatment Cuts Exacerbations in Bronchiectasis

Targeting inflammation at its root, a new therapy reduces bronchiectasis exacerbations and slows lung function decline, according to results from a Phase III clinical trial.

Targeted RA Therapies: Lessons from Aging Japan

In Japan, home to the world’s most rapidly aging society, managing rheumatoid arthritis (RA) in elderly patients has posed unique challenges for healthcare providers.

Dermatology Trials Face a Reckoning on Race and Ethnicity

In dermatology research, the use of race and ethnicity as population descriptors has come under increasing scrutiny, with experts questioning whether these broad categories obscure more than they reveal about human health.